Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies
Clinical trial NCT00081536 · UNKNOWN
Trial details
- NCT number
- NCT00081536
- Sponsor
- Aronex Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.